| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |